1-5 of 5
Kari Kendra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function

Andrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, Elizabeth McMichael, Thomas A. Mace, Brooke Benner, Kari Kendra, Amanda Campbell, Shalini Gautam, David Abood, Ian Landi, Vincent Hsu, Megan Duggan, Robert Wesolowski, Matthew Old, John Harrison Howard, Lianbo Yu, Nancy Stasik, Thomas Olencki, Natarajan Muthusamy, Susheela Tridandapani, John C. Byrd, Michael Caligiuri, William E. Carson
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (8): 1891–1904.
https://doi.org/10.1158/1078-0432.CCR-17-0691
Published: 12 April 2018
View article titled, Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function
Open the PDF for Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

Jason M. Zimmerer, Gregory B. Lesinski, Amy S. Ruppert, Michael D. Radmacher, Carl Noble, Kari Kendra, Michael J. Walker, William E. Carson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (18): 5900–5906.
https://doi.org/10.1158/1078-0432.CCR-08-0846
Published: 14 September 2008
View article titled, Gene Expression Profiling Reveals Similarities between the <em>In vitro</em> and <em>In vivo</em> Responses of Immune Effector Cells to IFN-α
Open the PDF for Gene Expression Profiling Reveals Similarities between the <em>In vitro</em> and <em>In vivo</em> Responses of Immune Effector Cells to IFN-α in another window
Includes: Supplementary data
Journal Articles

IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2

Jason M. Zimmerer, Amy M. Lehman, Amy S. Ruppert, Carl W. Noble, Thomas Olencki, Michael J. Walker, Kari Kendra, William E. Carson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1438–1445.
https://doi.org/10.1158/1078-0432.CCR-07-4178
Published: 03 March 2008
View article titled, IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m<sup>2</sup>
Open the PDF for IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m<sup>2</sup> in another window
Journal Articles

Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets In vitro and following Interleukin-2 Immunotherapy

Kimberly A. Varker, Sri Vidya Kondadasula, Michael R. Go, Gregory B. Lesinski, Rupa Ghosh-Berkebile, Amy Lehman, J. Paul Monk, Thomas Olencki, Kari Kendra, William E. Carson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5850–5858.
https://doi.org/10.1158/1078-0432.CCR-06-1159
Published: 04 October 2006
View article titled, Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets <em>In vitro</em> and following Interleukin-2 Immunotherapy
Open the PDF for Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets <em>In vitro</em> and following Interleukin-2 Immunotherapy in another window
Journal Articles

Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients

Bhuvaneswari Ramaswamy, Anthony D. Elias, Nicole T. Kelbick, Angela Dodley, Mark Morrow, Marsha Hauger, Joan Allen, Chris Rhoades, Kari Kendra, Helen X. Chen, S. Gail Eckhardt, Charles L. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (10): 3124–3129.
https://doi.org/10.1158/1078-0432.CCR-05-2603
Published: 17 May 2006
View article titled, Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients
Open the PDF for Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients in another window